This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horikawa, I. Articles by Barrett, J. C. Search for Related Content PubMed PubMed Citation Articles by Horikawa, I. Articles by Barrett, J. C.

Cloning and Characterization of the Promoter Region of Human Telomerase Reverse Transcriptase Gene

Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709

Activation of telomerase is one of the rate-limiting steps in human cell immortalization and carcinogenesis. Human telomerase is composed of at least two protein subunits and an RNA component. Regulation of expression of the catalytic subunit, human telomerase reverse transcriptase (hTERT), is suggested as the major determinant of the enzymatic activity. We report here the cloning and characterization of the 5'-regulatory region of the hTERT gene. The highly GC-rich content of the 5' end of the hTERT cDNA spans to the 5'-flanking region and intron 1, making a CpG island. A 1.7-kb DNA fragment encompassing the hTERT gene promoter was placed upstream of the luciferase reporter gene and transiently transfected into human cell lines of fibroblastic and epithelial origins that differed in their expression of the endogenous hTERT gene. Endogenous hTERT-expressing cells, but not nonexpressing cells, showed high levels of luciferase activity, suggesting that the regulation of hTERT gene expression occurs mainly at the transcriptional level. Additional luciferase assays using a series of constructs containing unidirectionally deleted fragments revealed that a 59-bp region (-208 to -150) is required for the maximal promoter activity. The region contains a potential Myc oncoprotein binding site (E-box), and cotransfection of a c-myc expression plasmid markedly enhanced the promoter activity, suggesting a role of the Myc protein in telomerase activation. Identification of the regulatory regions of the hTERT promoter sequence will be essential in understanding the molecular mechanisms of positive and negative regulation of telomerase.

This article has been cited by other articles:

				F Luan, H Liu, L Gao, J Liu, Z Sun, Y Ju, N Hou, C Guo, X Liang, L Zhang, et al. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT Gut, November 1, 2009; 58(11): 1528 - 1537. [Abstract] [Full Text] [PDF]

				J. E. Choi, H.-G. Kang, J. S. Jang, Y. Y. Choi, M. J. Kim, J. S. Kim, H.-S. Jeon, W. K. Lee, S. I. Cha, C. H. Kim, et al. Polymorphisms in Telomere Maintenance Genes and Risk of Lung Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2773 - 2781. [Abstract] [Full Text] [PDF]

				E. KUWADA, K. NOGUCHI, N. SEO, H. YAMASHIRO, and K. EGAWA A Novel Strategy of Cancer Gene Therapy by Transcriptional Targeting of an Allogeneic Histocompatibility Transgene Anticancer Res, April 1, 2009; 29(4): 1015 - 1022. [Abstract] [Full Text] [PDF]

				L. Liu, K. Ishihara, T. Ichimura, N. Fujita, S. Hino, S. Tomita, S. Watanabe, N. Saitoh, T. Ito, and M. Nakao MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity J. Biol. Chem., February 20, 2009; 284(8): 5165 - 5174. [Abstract] [Full Text] [PDF]

				A. Chatagnon, S. Bougel, L. Perriaud, J. Lachuer, J. Benhattar, and R. Dante Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells Carcinogenesis, January 1, 2009; 30(1): 28 - 34. [Abstract] [Full Text] [PDF]

				R. H. Kim, R. Kim, W. Chen, S. Hu, K.-H. Shin, N.-H. Park, and M. K. Kang Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells Carcinogenesis, December 1, 2008; 29(12): 2425 - 2431. [Abstract] [Full Text] [PDF]

				M NATARAJAN, S MOHAN, R KONOPINSKI, R A OTTO, and T S HERMAN Induced telomerase activity in primary aortic endothelial cells by low-LET {gamma}-radiation is mediated through NF-{kappa}B activation Br. J. Radiol., September 1, 2008; 81(969): 711 - 720. [Abstract] [Full Text] [PDF]

				M. Xu, W. Luo, D. J. Elzi, C. Grandori, and D. A. Galloway NFX1 Interacts with mSin3A/Histone Deacetylase To Repress hTERT Transcription in Keratinocytes Mol. Cell. Biol., August 1, 2008; 28(15): 4819 - 4828. [Abstract] [Full Text] [PDF]

				G. J. Bauerschmitz, T. Ranki, L. Kangasniemi, C. Ribacka, M. Eriksson, M. Porten, I. Herrmann, A. Ristimaki, P. Virkkunen, M. Tarkkanen, et al. Tissue-Specific Promoters Active in CD44+CD24-/low Breast Cancer Cells Cancer Res., July 15, 2008; 68(14): 5533 - 5539. [Abstract] [Full Text] [PDF]

				Y.-J. Chen, H. G. Campbell, A. K. Wiles, M. R. Eccles, R. R. Reddel, A. W. Braithwaite, and J. A. Royds PAX8 Regulates Telomerase Reverse Transcriptase and Telomerase RNA Component in Glioma Cancer Res., July 15, 2008; 68(14): 5724 - 5732. [Abstract] [Full Text] [PDF]

				X. Chen, J. Zhang, Y. Fang, C. Zhao, and Y. Zhu Ginsenoside Rg1 Delays Tert-Butyl Hydroperoxide-Induced Premature Senescence in Human WI-38 Diploid Fibroblast Cells J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2008; 63(3): 253 - 264. [Abstract] [Full Text] [PDF]

				M. Bellon and C. Nicot Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control J Natl Cancer Inst, January 16, 2008; 100(2): 98 - 108. [Abstract] [Full Text] [PDF]

				L. G. Wooten-Blanks, P. Song, C. E. Senkal, and B. Ogretmen Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1 FASEB J, October 1, 2007; 21(12): 3386 - 3397. [Abstract] [Full Text] [PDF]

				P. Oikonomou, I. Messinis, and A. Tsezou DNA Methylation Is Not Likely to Be Responsible for hTERT Expression in Premalignant Cervical Lesions Experimental Biology and Medicine, July 1, 2007; 232(7): 881 - 886. [Abstract] [Full Text] [PDF]

				S. Renaud, D. Loukinov, Z. Abdullaev, I. Guilleret, F. T. Bosman, V. Lobanenkov, and J. Benhattar Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene Nucleic Acids Res., February 28, 2007; 35(4): 1245 - 1256. [Abstract] [Full Text] [PDF]

				G.-S. Shieh, A.-L. Shiau, Y.-T. Yo, P.-R. Lin, C.-C. Chang, T.-S. Tzai, and C.-L. Wu Low-Dose Etoposide Enhances Telomerase-Dependent Adenovirus-Mediated Cytosine Deaminase Gene Therapy through Augmentation of Adenoviral Infection and Transgene Expression in a Syngeneic Bladder Tumor Model. Cancer Res., October 15, 2006; 66(20): 9957 - 9966. [Abstract] [Full Text] [PDF]

				D. Hoffmann and O. Wildner Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy. Mol. Cancer Ther., August 1, 2006; 5(8): 2013 - 2022. [Abstract] [Full Text] [PDF]

				T. Racek, N. Mise, Z. Li, A. Stoll, and B. M. Putzer C-terminal p73 Isoforms Repress Transcriptional Activity of the Human Telomerase Reverse Transcriptase (hTERT) Promoter J. Biol. Chem., December 9, 2005; 280(49): 40402 - 40405. [Abstract] [Full Text] [PDF]

				S. Renaud, D. Loukinov, F. T. Bosman, V. Lobanenkov, and J. Benhattar CTCF binds the proximal exonic region of hTERT and inhibits its transcription Nucleic Acids Res., December 2, 2005; 33(21): 6850 - 6860. [Abstract] [Full Text] [PDF]

				F. Faiola, X. Liu, S. Lo, S. Pan, K. Zhang, E. Lymar, A. Farina, and E. Martinez Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription Mol. Cell. Biol., December 1, 2005; 25(23): 10220 - 10234. [Abstract] [Full Text] [PDF]

				M. Quante, S. Heeg, A. von Werder, G. Goessel, C. Fulda, M. Doebele, H. Nakagawa, R. Beijersbergen, H. E. Blum, and O. G. Opitz Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis Carcinogenesis, November 1, 2005; 26(11): 1879 - 1889. [Abstract] [Full Text] [PDF]

				M. Takakura, S. Kyo, M. Inoue, W. E. Wright, and J. W. Shay Function of AP-1 in Transcription of the Telomerase Reverse Transcriptase Gene (TERT) in Human and Mouse Cells Mol. Cell. Biol., September 15, 2005; 25(18): 8037 - 8043. [Abstract] [Full Text] [PDF]

				L. G. Wooten and B. Ogretmen Sp1/Sp3-dependent Regulation of Human Telomerase Reverse Transcriptase Promoter Activity by the Bioactive Sphingolipid Ceramide J. Biol. Chem., August 12, 2005; 280(32): 28867 - 28876. [Abstract] [Full Text] [PDF]

				S. Wang and J. Zhu The hTERT Gene Is Embedded in a Nuclease-resistant Chromatin Domain J. Biol. Chem., December 31, 2004; 279(53): 55401 - 55410. [Abstract] [Full Text] [PDF]

				S. C. Verma, S. Borah, and E. S. Robertson Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Up-Regulates Transcription of Human Telomerase Reverse Transcriptase Promoter through Interaction with Transcription Factor Sp1 J. Virol., October 1, 2004; 78(19): 10348 - 10359. [Abstract] [Full Text] [PDF]

				L. Gewin, H. Myers, T. Kiyono, and D. A. Galloway Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex Genes & Dev., September 15, 2004; 18(18): 2269 - 2282. [Abstract] [Full Text] [PDF]

				B. S. Goueli and R. Janknecht Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf Mol. Cell. Biol., January 1, 2004; 24(1): 25 - 35. [Abstract] [Full Text] [PDF]

				J. Xiong, S. Fan, Q. Meng, L. Schramm, C. Wang, B. Bouzahza, J. Zhou, B. Zafonte, I. D. Goldberg, B. R. Haddad, et al. BRCA1 Inhibition of Telomerase Activity in Cultured Cells Mol. Cell. Biol., December 1, 2003; 23(23): 8668 - 8690. [Abstract] [Full Text] [PDF]

				N. A. Lanson Jr., P. L. Friedlander, P. Schwarzenberger, J. K. Kolls, and G. Wang Replication of an Adenoviral Vector Controlled by the Human Telomerase Reverse Transcriptase Promoter Causes Tumor-Selective Tumor Lysis Cancer Res., November 15, 2003; 63(22): 7936 - 7941. [Abstract] [Full Text] [PDF]

				H. R. McMurray and D. J. McCance Human Papillomavirus Type 16 E6 Activates TERT Gene Transcription through Induction of c-Myc and Release of USF-Mediated Repression J. Virol., September 15, 2003; 77(18): 9852 - 9861. [Abstract] [Full Text] [PDF]

				T. Takeda, H. Inaba, M. Yamazaki, S. Kyo, T. Miyamoto, S. Suzuki, T. Ehara, T. Kakizawa, M. Hara, L. J. DeGroot, et al. Tumor-Specific Gene Therapy for Undifferentiated Thyroid Carcinoma Utilizing the Telomerase Reverse Transcriptase Promoter J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3531 - 3538. [Abstract] [Full Text] [PDF]

				H. Ma, V. Urquidi, J. Wong, J. Kleeman, and S. Goodison Telomerase Reverse Transcriptase Promoter Regulation During Myogenic Differentiation of Human RD Rhabdomyosarcoma Cells Mol. Cancer Res., August 1, 2003; 1(10): 739 - 746. [Abstract] [Full Text] [PDF]

				T. Veldman, X. Liu, H. Yuan, and R. Schlegel Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter PNAS, July 8, 2003; 100(14): 8211 - 8216. [Abstract] [Full Text] [PDF]

				I. Horikawa and J. C. Barrett Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176. [Abstract] [Full Text] [PDF]

				T. Wirth, L. Zender, B. Schulte, B. Mundt, R. Plentz, K. L. Rudolph, M. Manns, S. Kubicka, and F. Kuhnel A Telomerase-dependent Conditionally Replicating Adenovirus for Selective Treatment of Cancer Cancer Res., June 15, 2003; 63(12): 3181 - 3188. [Abstract] [Full Text] [PDF]

				S. Wang and J. Zhu Evidence for a Relief of Repression Mechanism for Activation of the Human Telomerase Reverse Transcriptase Promoter J. Biol. Chem., May 23, 2003; 278(21): 18842 - 18850. [Abstract] [Full Text] [PDF]

				D. L. Levens Reconstructing MYC Genes & Dev., May 1, 2003; 17(9): 1071 - 1077. [Full Text] [PDF]

				H. Szutorisz, J. Lingner, A. P. Cuthbert, D. A. Trott, R. F. Newbold, and M. Nabholz A Chromosome 3-encoded Repressor of the Human Telomerase Reverse Transcriptase (hTERT) Gene Controls the State of hTERT Chromatin Cancer Res., February 1, 2003; 63(3): 689 - 695. [Abstract] [Full Text] [PDF]

				J. Won, J. Yim, and T. K. Kim Sp1 and Sp3 Recruit Histone Deacetylase to Repress Transcription of Human Telomerase Reverse Transcriptase (hTERT) Promoter in Normal Human Somatic Cells J. Biol. Chem., October 4, 2002; 277(41): 38230 - 38238. [Abstract] [Full Text] [PDF]

				Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF]

				I. Horikawa, P. L. Cable, S. J. Mazur, E. Appella, C. A. Afshari, and J. C. Barrett Downstream E-Box-mediated Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Transcription: Evidence for an Endogenous Mechanism of Transcriptional Repression Mol. Biol. Cell, August 1, 2002; 13(8): 2585 - 2597. [Abstract] [Full Text] [PDF]

				D. Lee, H.-Z. Kim, K. W. Jeong, Y. S. Shim, I. Horikawa, J. C. Barrett, and J. Choe Human Papillomavirus E2 Down-regulates the Human Telomerase Reverse Transcriptase Promoter J. Biol. Chem., July 26, 2002; 277(31): 27748 - 27756. [Abstract] [Full Text] [PDF]

				J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson Natural and pharmacological regulation of telomerase Nucleic Acids Res., February 15, 2002; 30(4): 839 - 865. [Abstract] [Full Text] [PDF]

				K. Nomoto, M. Maekawa, K. Sugano, M. Ushiama, N. Fukayama, S. Fujita, and T. Kakizoe Methylation Status and Expression of Human Telomerase Reverse Transcriptase mRNA in Relation to Hypermethylation of the p16 gene in Colorectal Cancers as Analyzed by Bisulfite PCR-SSCP Jpn. J. Clin. Oncol., January 1, 2002; 32(1): 3 - 8. [Abstract] [Full Text] [PDF]

				J. E. Prescott, R. C. Osthus, L. A. Lee, B. C. Lewis, H. Shim, J. F. Barrett, Q. Guo, A. L. Hawkins, C. A. Griffin, and C. V. Dang A Novel c-Myc-responsive Gene, JPO1, Participates in Neoplastic Transformation J. Biol. Chem., December 14, 2001; 276(51): 48276 - 48284. [Abstract] [Full Text] [PDF]

				A.-L. Ducrest, M. Amacker, Y. D. Mathieu, A. P. Cuthbert, D. A. Trott, R. F. Newbold, M. Nabholz, and J. Lingner Regulation of Human Telomerase Activity: Repression by Normal Chromosome 3 Abolishes Nuclear Telomerase Reverse Transcriptase Transcripts but Does Not Affect c-Myc Activity Cancer Res., October 1, 2001; 61(20): 7594 - 7602. [Abstract] [Full Text] [PDF]

				Y. Yokoyama, X. Wan, Y. Takahashi, A. Shinohara, and T. Tamaya Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus Mol. Hum. Reprod., September 1, 2001; 7(9): 853 - 857. [Abstract] [Full Text] [PDF]

				L. Gewin and D. A. Galloway E Box-Dependent Activation of Telomerase by Human Papillomavirus Type 16 E6 Does Not Require Induction of c-myc J. Virol., August 1, 2001; 75(15): 7198 - 7201. [Abstract] [Full Text]

				I. Horikawa and J. C. Barrett cis-Activation of the Human Telomerase Gene (hTERT) by the Hepatitis B Virus Genome J Natl Cancer Inst, August 1, 2001; 93(15): 1171 - 1173. [Full Text] [PDF]

				K. S. J. Elenitoba-Johnson Complex Regulation of Telomerase Activity : Implications for Cancer Therapy Am. J. Pathol., August 1, 2001; 159(2): 405 - 410. [Full Text]

				D. L. Crowe, D. C. Nguyen, K. J. Tsang, and S. Kyo E2F-1 represses transcription of the human telomerase reverse transcriptase gene Nucleic Acids Res., July 1, 2001; 29(13): 2789 - 2794. [Abstract] [Full Text] [PDF]

				I. Braunstein, O. Cohen-Barak, C. Shachaf, Y. Ravel, M. Yalon-Hacohen, G. B. Mills, M. Tzukerman, and K. L. Skorecki Human Telomerase Reverse Transcriptase Promoter Regulation in Normal and Malignant Human Ovarian Epithelial Cells Cancer Res., July 1, 2001; 61(14): 5529 - 5536. [Abstract] [Full Text] [PDF]

				F. Pendino, M. Flexor, F. Delhommeau, D. Buet, M. Lanotte, and E. Ségal-Bendirdjian Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation PNAS, May 18, 2001; (2001) 111464998. [Abstract] [Full Text]

				T. Veldman, I. Horikawa, J. C. Barrett, and R. Schlegel Transcriptional Activation of the Telomerase hTERT Gene by Human Papillomavirus Type 16 E6 Oncoprotein J. Virol., May 1, 2001; 75(9): 4467 - 4472. [Abstract] [Full Text]

				K. Liu, R. J. Hodes, and N.-p. Weng Cutting Edge: Telomerase Activation in Human T Lymphocytes Does Not Require Increase in Telomerase Reverse Transcriptase (hTERT) Protein But Is Associated with hTERT Phosphorylation and Nuclear Translocation J. Immunol., April 15, 2001; 166(8): 4826 - 4830. [Abstract] [Full Text] [PDF]

				H. Yang, S. Kyo, M. Takatura, and L. Sun Autocrine Transforming Growth Factor {beta} Suppresses Telomerase Activity and Transcription of Human Telomerase Reverse Transcriptase in Human Cancer Cells Cell Growth Differ., February 1, 2001; 12(2): 119 - 127. [Abstract] [Full Text]

				S. F. Hoare, L. A. Bryce, G. B. A. Wisman, S. Burns, J. J. Going, A. G. J. van der Zee, and W. N. Keith Lack of Telomerase RNA Gene hTERC Expression in Alternative Lengthening of Telomeres Cells Is Associated with Methylation of the hTERC Promoter Cancer Res., January 1, 2001; 61(1): 27 - 32. [Abstract] [Full Text]

				M. Tzukerman, C. Shachaf, Y. Ravel, I. Braunstein, O. Cohen-Barak, M. Yalon-Hacohen, and K. L. Skorecki Identification of a Novel Transcription Factor Binding Element Involved in the Regulation by Differentiation of the Human Telomerase (hTERT) Promoter Mol. Biol. Cell, December 1, 2000; 11(12): 4381 - 4391. [Abstract] [Full Text]

				J. Gu, S. Kagawa, M. Takakura, S. Kyo, M. Inoue, J. A. Roth, and B. Fang Tumor-specific Transgene Expression from the Human Telomerase Reverse Transcriptase Promoter Enables Targeting of the Therapeutic Effects of the Bax Gene to Cancers Cancer Res., October 1, 2000; 60(19): 5359 - 5364. [Abstract] [Full Text]

				S. Misiti, S. Nanni, G. Fontemaggi, Y.-S. Cong, J. Wen, H. W. Hirte, G. Piaggio, A. Sacchi, A. Pontecorvi, S. Bacchetti, et al. Induction of hTERT Expression and Telomerase Activity by Estrogens in Human Ovary Epithelium Cells Mol. Cell. Biol., June 1, 2000; 20(11): 3764 - 3771. [Abstract] [Full Text]

				Q. Gao, A. Kumar, S. Srinivasan, L. Singh, H. Mukai, Y. Ono, D. E. Wazer, and V. Band PKN Binds and Phosphorylates Human Papillomavirus E6 Oncoprotein J. Biol. Chem., May 12, 2000; 275(20): 14824 - 14830. [Abstract] [Full Text] [PDF]

				H. Kitaura, M. Shinshi, Y. Uchikoshi, T. Ono, T. Tsurimoto, H. Yoshikawa, S. M. M. Iguchi-Ariga, and H. Ariga Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21cip1/waf1/sdi1 in DNA Replication and Transcription J. Biol. Chem., March 31, 2000; 275(14): 10477 - 10483. [Abstract] [Full Text] [PDF]

				S. K. Dessain, H.-y. Yu, R. R. Reddel, R. L. Beijersbergen, and R. A. Weinberg Methylation of the Human Telomerase Gene CpG Island Cancer Res., February 1, 2000; 60(3): 537 - 541. [Abstract] [Full Text]

				S. Oh, Y. Song, J. Yim, and T. K. Kim The Wilms' Tumor 1 Tumor Suppressor Gene Represses Transcription of the Human Telomerase Reverse Transcriptase Gene J. Biol. Chem., December 24, 1999; 274(52): 37473 - 37478. [Abstract] [Full Text] [PDF]

				T. R. Devereux, I. Horikawa, C. H. Anna, L. A. Annab, C. A. Afshari, and J. C. Barrett DNA Methylation Analysis of the Promoter Region of the Human Telomerase Reverse Transcriptase (hTERT) Gene Cancer Res., December 1, 1999; 59(24): 6087 - 6090. [Abstract] [Full Text] [PDF]

				J.-P. LIU Studies of the molecular mechanisms in the regulation of telomerase activity FASEB J, December 1, 1999; 13(15): 2091 - 2104. [Abstract] [Full Text]

				Y.-S. Cong and S. Bacchetti Histone Deacetylation Is Involved in the Transcriptional Repression of hTERT in Normal Human Cells J. Biol. Chem., November 10, 2000; 275(46): 35665 - 35668. [Abstract] [Full Text] [PDF]

				L. Yin, A. K. Hubbard, and C. Giardina NF-kappa B Regulates Transcription of the Mouse Telomerase Catalytic Subunit J. Biol. Chem., November 17, 2000; 275(47): 36671 - 36675. [Abstract] [Full Text] [PDF]

				K. Nozawa, K. Maehara, and K.-i. Isobe Mechanism for the Reduction of Telomerase Expression during Muscle Cell Differentiation J. Biol. Chem., June 15, 2001; 276(25): 22016 - 22023. [Abstract] [Full Text] [PDF]

				B. Ogretmen, J. M. Kraveka, D. Schady, J. Usta, Y. A. Hannun, and L. M. Obeid Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition in the A549 Human Lung Adenocarcinoma Cell Line J. Biol. Chem., August 24, 2001; 276(35): 32506 - 32514. [Abstract] [Full Text] [PDF]

				J. S. Knight, M. A. Cotter II, and E. S. Robertson The Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus Transactivates the Telomerase Reverse Transcriptase Promoter J. Biol. Chem., June 15, 2001; 276(25): 22971 - 22978. [Abstract] [Full Text] [PDF]

				F. Pendino, M. Flexor, F. Delhommeau, D. Buet, M. Lanotte, and E. Segal-Bendirdjian Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation PNAS, June 5, 2001; 98(12): 6662 - 6667. [Abstract] [Full Text] [PDF]